- Home
- KAVL vs IMCC Comparison
KAVL vs IMCC Comparison
Compare KAVL & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KAVL
- IMCC
- Stock Information
- Founded
- KAVL 1998
- IMCC 1980
- Country
- KAVL United States
- IMCC Israel
- Employees
- KAVL N/A
- IMCC N/A
- Industry
- KAVL Medicinal Chemicals and Botanical Products
- IMCC Medicinal Chemicals and Botanical Products
- Sector
- KAVL Health Care
- IMCC Health Care
- Exchange
- KAVL Nasdaq
- IMCC Nasdaq
- Market Cap
- KAVL 8.9M
- IMCC 7.5M
- IPO Year
- KAVL N/A
- IMCC N/A
- Fundamental
- Price
- KAVL $1.18
- IMCC $2.37
- Analyst Decision
- KAVL
- IMCC
- Analyst Count
- KAVL 0
- IMCC 0
- Target Price
- KAVL N/A
- IMCC N/A
- AVG Volume (30 Days)
- KAVL 1.1M
- IMCC 16.6K
- Earning Date
- KAVL 02-13-2025
- IMCC 11-14-2024
- Dividend Yield
- KAVL N/A
- IMCC N/A
- EPS Growth
- KAVL N/A
- IMCC N/A
- EPS
- KAVL N/A
- IMCC N/A
- Revenue
- KAVL $10,108,906.00
- IMCC $38,042,859.00
- Revenue This Year
- KAVL $652.90
- IMCC $22.59
- Revenue Next Year
- KAVL N/A
- IMCC $32.86
- P/E Ratio
- KAVL N/A
- IMCC N/A
- Revenue Growth
- KAVL N/A
- IMCC N/A
- 52 Week Low
- KAVL $0.58
- IMCC $1.13
- 52 Week High
- KAVL $9.69
- IMCC $8.10
- Technical
- Relative Strength Index (RSI)
- KAVL 60.50
- IMCC 48.84
- Support Level
- KAVL $0.95
- IMCC $2.11
- Resistance Level
- KAVL $1.22
- IMCC $2.53
- Average True Range (ATR)
- KAVL 0.20
- IMCC 0.32
- MACD
- KAVL 0.02
- IMCC -0.00
- Stochastic Oscillator
- KAVL 51.76
- IMCC 33.91
About KAVL Kaival Brands Innovations Group Inc.
Kaival Brands Innovations Group Inc is focused on growing and incubating innovative and profitable products. The company is engaged in the sale, marketing and distribution of electronic nicotine delivery system (ENDS) products and related components. Its primary product includes Bidi Stick. The BIDI Stick comes in a variety of flavor options for adult cigarette smokers.
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.